Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 175 participants.
Also called NCT02489539
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 175 participants
- Sponsor
- Registry
-
NCT02489539
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Results first posted
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT02489539. Non-randomized; no masking; primary purpose treatment. Start 2017-12-19 (actual); primary completion 2023-05-25 (actual). Results posted on 2024-04-04.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms
- Condition
- Aortic Aneurysm, Abdominal
- Intervention (Device)
- GORE® EXCLUDER® Conformable AAA Endoprosthesis
- Lead sponsor
- W.L.Gore & Associates
Record details
- Record id
cardio:ct-nct02489539- Content hash
9b75297fd72c6044f7519c357a79df956faa7996b903eeeb50ffec7917871466